This article is for educational purposes only and does not constitute legal advice.
One of the most expensive M&A assumptions in founder-led companies is that a stock deal or reverse triangular merger automatically solves the consent problem.
Sometimes it helps. Sometimes it does not. The answer depends less on deal folklore and more on what the actual contracts, licenses, leases, debt documents, and permits say about assignment, change of control, operation of law, or successor use.
That matters because consent work is not just a clerical closing item. It affects structure choice, bargaining leverage, disclosure schedule accuracy, and sometimes whether the buyer will sign at all.
In this guide
- Why structure changes the consent analysis
- Which clauses create the most trouble in founder exits
- Where companies usually discover consent problems too late
- A copy/paste contract-consent inventory
Deal structure changes the consent profile
A direct stock sale often leaves the legal entity in place, which can reduce assignment issues. A reverse triangular merger can also preserve the target entity, which is one reason buyers like it. But “often” is not “always.” If the contract prohibits a change of control, references assignment by operation of law, or is drafted unusually broadly, entity survival may not save the day.
By contrast, asset sales and forward mergers are much more likely to trigger consent requirements because contracts, permits, and licenses may need to move to a different legal holder. That is why structure selection and contract review should happen in the same conversation, not in parallel silos.
- Stock sale: fewer transfer mechanics, but change-of-control language can still bite.
- Reverse triangular merger: often helpful for contract continuity, but not a free pass.
- Forward merger or asset sale: much more likely to require counterparty action.
- Regulated rights and personal-service style rights require extra skepticism regardless of structure.
Founders usually miss the same contract buckets
The obvious place to look is the customer and vendor stack. The less obvious places are usually the ones that hurt: office leases, debt instruments, partner agreements, API or data licenses, source-code or content licenses, insurance-related rights, key service agreements, and government-facing permits or approvals.
This issue shows up even outside a pure sale process. Montague’s startup office lease checklist highlights how a merger or change of control can create landlord-consent problems if assignment language is loose or one-sided.
Make the consent inventory a real workstream
A practical seller-side approach is to turn consent review into an owned checklist before the second draft of the acquisition agreement. That checklist should tie directly to the disclosure workstream, including the contract-organizing discipline described in Montague’s disclosure-schedule owner matrix.
The question for each material agreement is not simply “Is there an anti-assignment clause?” It is also: what transaction structures does the language plausibly reach, who grants the consent, what notice or cure timing exists, and how much operational leverage does the counterparty gain once it knows a sale is pending?
Use the structure choice strategically, not defensively
Sometimes the right answer is to preserve the entity and use a merger structure that minimizes consents. Sometimes the better answer is to accept that consents are unavoidable and start with the agreements that can actually delay closing. Montague’s private-company merger-agreement guide is a helpful reminder that structure should be chosen for execution and risk reasons, not because one side heard that a reverse triangular merger is a universal cure.
The earlier this analysis is done, the more freedom the seller keeps. The later it is done, the more likely the buyer uses the consent burden to renegotiate price, hold back proceeds, or demand a more seller-unfriendly closing package.
Copy/paste contract-consent inventory
CONTRACT CONSENT INVENTORY 1. For each material agreement, answer: - Counterparty: - Agreement type: - Renewal / expiration date: - Revenue-critical or operationally critical? yes / no 2. Structure sensitivity - Direct stock sale issue? yes / no / unclear - Reverse triangular merger issue? yes / no / unclear - Forward merger issue? yes / no / unclear - Asset sale issue? yes / no / unclear 3. Clause review - Assignment restriction: - Change-of-control restriction: - “By operation of law” language: - Successor / assign language: - Consent standard (sole discretion / reasonable / silent): - Notice timing: - Cure rights: - Fees or economics triggered by consent: 4. High-risk buckets - Customer contracts - Key vendor / supply contracts - Office / facility leases - Software, data, API, or content licenses - Debt / security documents - Insurance or benefits administration agreements - Strategic partnership / reseller / OEM agreements - Government permits / approvals / regulated licenses 5. Negotiation impact - Can the transaction structure be adjusted to reduce consents? - Which consents must be obtained before signing vs before closing? - Which consents are disclose-only risks? - Which counterparties gain repricing leverage if notified? 6. Owner / deadline - Business owner: - Legal owner: - Counterparty-contact owner: - Target date: - Backup plan if consent is refused:
